Shares of AngioDynamics (ANGO) have gained 26.5% over the past four weeks to close the last trading session at 7.65,buttherecouldstillbeasolidupsideleftinthestockifshort−termpricetargetsofWallStreetanalystsareanyindication.Goingbythepricetargets,themeanestimateof13.33 indicates a potential upside of 74.3%.The average comprises three short-term price targets ranging from a low of 13toahighof14, with a standard deviation of $0.58. While the lowest estimate indicates a ...